title: Trade-off between the benefits of lithium treatment and the risk of chronic kidney disease.
authors.forename: William R
authors.initials: WR
authors.lastname: Adam
authors.forename: Isaac
authors.initials: I
authors.lastname: Schweitzer
authors.forename: Isaac
authors.initials: I
authors.lastname: Sshweitzer
authors.forename: Rowan G
authors.initials: RG
authors.lastname: Walker
mesh_terms: D000339:Affect / Q000187:drug effects*; D018692:Antimanic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D016651:Lithium Carbonate / Q000009:adverse effects*; D018579:Patient Selection; D051436:Renal Insufficiency, Chronic / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D018692:Antimanic Agents; D016651:Lithium Carbonate